Skip to main content
CRS 2024 Annual Meeting and Exposition Main banner
Final Program


CRS Abstract Guide
  1. Home



Industry-Supported Educational Workshops


The Controlled Release Society invites you to attend our Educational Workshops during the 2024 Annual Meeting and Exposition. The CRS Annual Meeting is the premier event in delivery science & technology. This must-attend, high-caliber scientific conference draws over 1,000 international attendees with world-renowned speakers, working in drug delivery, consumer and diversified products, preclinical sciences and animal health.



Workshop Schedule

Monday, July 8




Oral Drug Delivery From Today to Tomorrow: 

Latest Innovations and Best Practices


Part I: 9:00 am to 12:20 pm

   You don’t want to miss the opportunity to learn or refresh your knowledge on oral controlled release technologies and make contacts with subject matter experts


Part II: 1:20 pm to 5:00 pm 

Join us and learn more about the cutting edge science and technology of oral drug delivery systems



Are you attending the CRS Annual Meeting because of your interest in Drug Delivery and Controlled Release Systems? 

Many of these delivery systems are administered orally. You may be a clinician in search of better clinical outcomes, achemist with pioneering new molecules, an industrial formulator with challenging APIs, a product owner in search of life cycle management strategies for your drug product or an engineer looking for advanced manufacturing technologies i.e. widely different motivations for attending this conference and workshop.

Attending this workshop is a must, as you'll have access to a group of seasoned presenters in oral drug delivery who have been there and done that’ with a wealth of experience of both successes and setbacks. This presents a unique opportunity to delve into the intricacies of formulating, developing, and manufacturing oral dosage forms, leveraging cutting-edge science and technology.

The agenda contains fundamentals, current hot topics as well as cutting edge forthcoming technologies backed with science and applications. There will be interactive discussions and real-life case studies to showcase challenges and potential solutions. Join us at this workshop to exchange insights, identify valuable resources, and navigate the complex landscape of oral drug delivery with confidence.

Agenda


Sponsored By:
   






 

Recent Advances in the Use of Phospholipid Excipients

8:00 am to 12:00 pm

The goals of the workshop are to inform on the basic properties of phospholipid excipients, including physical chemistry aspects, and their use in pharmaceutical technology. Target group are interested academic researchers as well as pharmaceutical industrial scientists interested in the use of phospholipid excipients. The audience will be informed on selection and use of phospholipids in obtaining optimal liposomal dosage forms for various applications, including parenteral depot formulations and hot-melt extrusion for oral formulations of poorly soluble drugs, and on the latest advances on phospholipids in gene replacement therapy, infectious diseases, targeted therapy, nanobubble ablation in ophthalmology.

 At the completion of this activity, participants will know:

  • To demonstrate the correlation between the physicochemical properties of the used phospholipids and phospholipid-based dosage forms and the performance of the drug substance (toxicity, efficacy, bioavailability and pharmacokinetics) with mentioned delivery systems.

 

  • The audience will be informed on the latest advances in this phospholipid area in two sessions: The first session is a more general session on the use of phospholipids as excipients, whereas the second session will focus on application examples from liposomes and lipid nanoparticles (LNPs).


Agenda

 


Sponsored By:




The Application of AI to Drug Delivery and Controlled Release

8:00 am to 12:00 pm


The workshop addresses the pressing need for innovative solutions in drug delivery, especially for nucleic acids/macromolecules, by exploring the transformative potential of AI and computational tools to revolutionize the field. Geared towards academics and biotech industry professionals, this workshop will prioritize fostering collaboration, sharing cutting-edge research, and facilitating discussions on how AI can best facilitate research and development of drug delivery technologies.

Agenda


Sponsored By:





Debunking the Myths of Subcutaneous Drug Delivery

1:00 pm to 5:00 pm

The subcutaneous (SC) route of drug administration has increasingly gained regulatory acceptance and patient/HCP preference, particularly for delivery of biological therapeutics. In this educational workshop, we aim to debunk some myths surrounding subcutaneous drug delivery, and to provide guidance for scientists from both Industry and Academia who are in the field of SC drug development and delivery. Topics include the misperceptions with SC (1) pain associated with delivery of large doses and volumes, (2) immunogenicity, (3) low and unpredictable bioavailability, and (4) need for extensive clinical trials.

 

   At the completion of this activity, participants will know

  • We will discuss some misconceptions surrounding subcutaneous drug delivery and how to navigate the SC drug development and delivery process.

 

  • SC drug delivery is not limited to small volumes. We will discuss options and key parameters for large volume delivery.

 

  • SC drug delivery is not prohibited by immunogenicity. We will provide the current understanding of SC immunogenicity and key factors affecting risk.

 

  • SC bioavailability is not limiting. We will discuss unvalidated views that SC delivery results in low or unpredictable bioavailability and share strategies and methods for optimizing and characterizing it.

 

  • The clinical development path for SC drugs does not have to be long and complicated. We will discuss strategies for a streamlined approach from early to registrational trials.


    Agenda


Sponsored By:






Pediatric Modified Release -What’s the Problem and What are Some Solutions?

1:00 pm to 5:00 pm

 

The workshop is centered on obtaining expert input into the challenges associated with modified release formulations (especially parenterals) in pediatric patients, and some technologies old and new emerging as solutions to these challenges. For both aspects there will be a speakers with regulatory, industry and academic backgrounds, and separate panel sessions with Q&A on challenges and solutions. Industrial formulation and regulatory scientists presented with these challenges, academics looking to enter this research field and students active in the pediatric formulation field will gain the most from this workshop.


Agenda


Sponsored By:



 

Long Acting Injectables: Microsphere and Implant Design, Development and Scale Up Using ChronijectTM with ViatelTM Lactide / Glycolide Polymers

1:00 pm to 5:00 pm

 

This event will focus on development and scale-up of long-acting injectable microspheres and implants.  Attendees will have an opportunity to learn about the selection of bioresorbable polymers and optimization of long-acting formulations with releases ranging from weeks to one year. Ashland, Oakwood Labs, MeltPrep and Sever will present together, respectively discussing how Ashland’s viatelTM bioresorbable polymers are optimized in various parenteral formulations. Oakwood Labs’ will discuss their ChronijectTM microsphere technology platform that offers reproducible, scalable, and consistent critical quality attributes under cGMP for multiple therapeutic indications.  Following talks will focus on implants, where MeltPrep will discuss a straightforward formulation screening tool with their vacuum compression molding (VCM) technology, while Sever Pharma will focus on their extrusion technologies, capable of forming bioresorbable implants at commercial scale.


Agenda

 


Sponsored By:





Therapeutic Genome Editing: Tools, Delivery Systems, Prospects and Challenges

1:00 PM – 5:00 PM

 

Recent progress in the development of genome editing technologies based on programmable nucleases have significantly improved our ability to make precise changes in the genomes of eukaryotic cells. Their success in the clinic will depend on having precise and safe delivery systems. This workshop will cover recent advances in editing tools, targeted delivery systems, and high throughput screening platforms to aid the discovery process as well as manufacturing, analytical and regulatory challenges of bringing these novel medicines to patients. The key considerations and challenges of realising the transformative potential of gene therapy in the clinic and enabling a cure for many diseases will be discussed.

 

Agenda


Sponsored By:





Contact Information:



Sponsorship/Funding:
Amanda Bray
Industry Relations Manager
+1.856.437.4750
abray@controlledreleasesociety.org

 


Workshop Application, Program/Speaker Management, Logistics:
Tara Locantore
Meeting Coordinator
+1.856.380.6879
tlocantore@controlledreleasesociety.org



General Meeting/Registration Questions:
meetings@controlledreleasesociety.org